Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Hypertension. 2006;48:950-957
Published online before print September 18, 2006, doi: 10.1161/01.HYP.0000242336.58387.1f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
48/5/950    most recent
01.HYP.0000242336.58387.1fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, F.
Right arrow Articles by Dusting, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, F.
Right arrow Articles by Dusting, G. J.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Hypertension. 2006;48:950.)
© 2006 American Heart Association, Inc.

Original Articles

NO Modulates NADPH Oxidase Function Via Heme Oxygenase-1 in Human Endothelial Cells

Fan Jiang; Sarah J. Roberts; Srinivasa raju Datla; Gregory J. Dusting

From the Bernard O’Brien Institute of Microsurgery, University of Melbourne, Fitzroy, Victoria 3065, Australia.

Correspondence to Fan Jiang, Bernard O’Brien Institute of Microsurgery, 42 Fitzroy St, Fitzroy, Victoria 3065, Australia. E-mail fjiang{at}unimelb.edu.au

NO is known to induce expression of heme oxygenase-1, an antioxidant enzyme in blood vessels. We tested whether NO might modulate the endothelial NADPH oxidase function via heme oxygenase-1. In human microvascular endothelial cells, the NO donor DETA-NONOate (0.1 to 1 mmol/L) strongly induced expression of heme oxygenase-1 but not Cu/Zn superoxide dismutase. This was associated with a reduction of the superoxide-generating capacity of NADPH oxidase, an effect that depended on de novo gene transcription and heme oxygenase-1 activity. Activation of NADPH oxidase by tumor necrosis factor (TNF) {alpha} increased generation of reactive oxygen species. DETA-NONOate alone had little effect on TNF-stimulated reactive oxygen species, but it enhanced the TNF response when: (1) heme oxygenase-1 expression was blocked with specific small-interfering RNA; (2) heme oxygenase-1 activity was blocked by zinc-protoporphyrin; or (3) NADPH oxidase activity was blocked by diphenyleneiodonium. Moreover, the heme oxygenase-1 end product bilirubin directly inhibited fully functional NADPH oxidase and seemed to interrupt the assembly and activation of the oxidase. In conclusion, NO may modulate superoxide production by NADPH oxidase in human vascular endothelial cells, at least partly by inducing heme oxygenase-1. Our results indicate that suppression of NADPH oxidase-dependent reactive oxygen species formation may represent a novel mechanism underlying the cardiovascular protective actions of heme oxygenase-1 and bilirubin.


Key Words: bilirubin • endothelium • heme oxygenase-1 • NADPH oxidase • nitric oxide • oxidant stress


Related Article:

Heme Oxygenase-1 Inhibition of Nox Oxidase Activation Is a Microvascular Endothelial Antioxidant Effect of NO
Michael S. Wolin and Nader G. Abraham
Hypertension 2006 48: 826-827. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Vera, J. P. Granger, and D. E. Stec
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R738 - R743.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Y. O. Ilbey, E. Ozbek, M. Cekmen, A. Simsek, A. Otunctemur, and A. Somay
Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways
Hum. Reprod., July 1, 2009; 24(7): 1717 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L. Gao and G. E. Mann
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Cardiovasc Res, April 1, 2009; 82(1): 9 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Datla, H. Peshavariya, G. J. Dusting, K. Mahadev, B. J. Goldstein, and F. Jiang
Important Role of Nox4 Type NADPH Oxidase in Angiogenic Responses in Human Microvascular Endothelial Cells In Vitro
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2319 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. R. Datla, G. J. Dusting, T. A. Mori, C. J. Taylor, K. D. Croft, and F. Jiang
Induction of Heme Oxygenase-1 In Vivo Suppresses NADPH Oxidase Derived Oxidative Stress
Hypertension, October 1, 2007; 50(4): 636 - 642.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Selemidis, G. J. Dusting, H. Peshavariya, B. K. Kemp-Harper, and G. R. Drummond
Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells
Cardiovasc Res, July 15, 2007; 75(2): 349 - 358.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. S. Wolin and N. G. Abraham
Heme Oxygenase-1 Inhibition of Nox Oxidase Activation Is a Microvascular Endothelial Antioxidant Effect of NO
Hypertension, November 1, 2006; 48(5): 826 - 827.
[Full Text] [PDF]


Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.